NEW YORK, May 15, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Foot Locker, Inc. (NYSE: FL)’s sale to DICK’S Sporting Goods, Inc. Under the terms of the proposed transaction, Foot Locker shareholders can elect to receive either (i) $24.00 in cash or (ii) 0.1168 shares of DICK’S common stock for each share of Foot Locker c ...

Core Viewpoint - Compass Diversified (CODI) is under investigation for potential securities fraud and unlawful business practices following the disclosure of irregularities in its subsidiary, Lugano Holding, Inc. [1][2] Group 1: Investigation Details - Pomerantz LLP is investigating claims on behalf of investors of CODI regarding possible securities fraud or unlawful business practices [1] - On May 7, 2025, CODI announced a non-reliance on its financial statements for fiscal 2024 due to an ongoing internal investigation into Lugano Holding [2] - The Audit Committee of CODI's Board of Directors initiated an investigation after concerns were raised about Lugano's inventory financing practices, which identified irregularities in non-CODI financing, accounting, and inventory practices [2] Group 2: Financial Impact - Following the announcement of the investigation, CODI's stock price dropped by $10.70 per share, representing a decline of 62.03%, closing at $6.55 per share on May 8, 2025 [2]

NEW YORK, May 7, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:FARO Technologies, Inc. (NASDAQ: FARO)'s sale to AMETEK, Inc. for $44.00 per share in cash. If you are a FARO shareholder, click here to learn more about your rights and options.AvidXchange Holdings, Inc. (NASDAQ: AVDX)'s sale to TPG for $10.00 per share in cash. If ...

NEW YORK, May 05, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Altria Group, Inc. (“Altria” or the “Company”) (NYSE: MO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Altria and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.  [Click here for information about joining the class action] On April 2, 2025, Deu ...

NEW YORK, May 05, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Wabash National Corporation (“Wabash” or the “Company”) (NYSE: WNC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Wabash and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.  [Click here for information about joining the class action] On April 30 ...

NEW YORK, May 01, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Coeptis Therapeutics Holdings, Inc. (NASDAQ: COEP)’s merger with Z Squared Inc. If you are a Coeptis shareholder, click here to learn more about your legal rights and options. Pacific Premier Bancorp, Inc. (NASDAQ: PPBI)’s sale to Columbia Banking System, Inc. ...

Core Viewpoint - ICU Medical, Inc. is under investigation for potential securities fraud and unlawful business practices following a warning from the FDA regarding unauthorized changes to its infusion pump products [1][2]. Group 1: FDA Warning and Product Issues - On April 22, 2025, ICU disclosed that it received a warning letter from the FDA, which cited unauthorized modifications to two of its infusion pump products [2]. - The FDA's letter described the pumps as "adulterated" and "misbranded," indicating that the changes could significantly affect the functionality of the devices, particularly their delivery profile and alarm functionality [2]. - Concerns were raised about the safety and efficacy of the devices due to these modifications, questioning the adequacy of ICU's regulatory disclosures [2]. Group 2: Stock Market Reaction - Following the FDA warning, ICU's stock price dropped by $6.04 per share, or 4.42%, closing at $130.68 per share on April 22, 2025 [3]. Group 3: Legal Investigation - Pomerantz LLP is investigating claims on behalf of ICU investors regarding potential securities fraud or other unlawful business practices by the company and its officers or directors [1].

Core Insights - Moore Law, PLLC is investigating potential claims against OSI Systems, Inc. following a report from Culper Research that raises serious allegations about the company's financial disclosures and growth claims [1][2]. Group 1: Allegations and Investigations - Culper Research published a report on March 13, 2025, alleging that OSI's reported growth in Mexico revenues is "largely an illusion" [2]. - The report accuses OSI of downplaying U.S. Department of Justice investigations by providing "deliberately vague and misleading disclosures" [2]. - Following the report's publication, OSI's stock price fell by $6.35 per share, or 3.5%, closing at $175.31 per share on the same day [2]. Group 2: Company Background - OSI Systems, Inc. is publicly traded on NASDAQ under the ticker OSIS [1]. - Moore Law, PLLC specializes in holding corporate officers and directors accountable for various forms of corporate misconduct, including breaches of fiduciary duty and fraud [3].

Core Insights - Moore Law, PLLC is investigating potential claims against e.l.f. Beauty, Inc. following a report from Muddy Waters Research that alleges the company materially overstated its revenue over the past three quarters [1][2] Group 1: Allegations Against e.l.f. Beauty - Muddy Waters Research reported that e.l.f. Beauty's management recognized issues with its growth narrative in Q2 FY24 due to rising inventory levels, leading to inflated revenue and profits [2] - The report claims that e.l.f. Beauty made false and misleading statements regarding its inventory levels, attributing them to changes in sourcing practices rather than declining sales [3] - e.l.f. Beauty allegedly reported inflated revenue, profits, and inventory over several quarters to maintain investor confidence, resulting in overstated business and financial prospects [3] Group 2: Stock Performance - Year-to-date, e.l.f. Beauty's stock price has decreased by approximately 52% [4]

Core Viewpoint - Moore Law, PLLC is investigating potential claims against AppLovin Corporation based on allegations from securities investment research firms regarding manipulative advertising practices [1][2] Group 1: Allegations Against AppLovin - Culper Research and Fuzzy Panda Research issued short reports alleging that AppLovin is reverse-engineering and exploiting advertising data from Meta Platforms [2] - The reports claim that AppLovin employs manipulative practices to artificially inflate ad click-through and app download rates, including self-clicking ads and design gimmicks that trigger forced downloads [2] Group 2: Market Reaction - Following the release of the investigative reports, the stock price of AppLovin experienced a significant decline, reflecting a nearly 22% drop [3]